Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
OrganiGram Holdings ( (TSE:OGI) ) has issued an announcement.
Organigram Holdings reported a 17% year-over-year increase in net revenue for Q1 Fiscal 2025, reaching $42.7 million. The company completed the acquisition of Motif Labs, strengthening its position as a market leader in Canada’s recreational cannabis sector. The integration of Motif is expected to yield over $10 million in annual run-rate synergies within 24 months. Organigram also launched Edison Sonics, utilizing proprietary FAST™ nanoemulsion technology for faster cannabinoid impact. With a strong balance sheet and negligible debt, the company continues to expand its market reach while maintaining its leadership in several cannabis product categories.
More about OrganiGram Holdings
Organigram Holdings Inc. is a leading licensed producer of cannabis in Canada. The company focuses on recreational cannabis products and holds a strong market position with a diverse product portfolio including vapes, pre-rolls, and edibles. Organigram aims to expand its presence in international markets and drive innovation within its operations and product offerings.
YTD Price Performance: 4.22%
Average Trading Volume: 743,972
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $209.4M
See more data about OGI stock on TipRanks’ Stock Analysis page.
